Pfanstiehl history

1930 – Babson Brothers, Inc., a Chicago-area manufacturer and distributor of dairy industry supplies, joins Pfanstiehl, assisting with financial and management support.

1942 – Pfanstiehl Chemical becomes a wholly-owned subsidiary of Babson, operating three separate divisions: fine chemicals, metallurgical products, and dairy sanitation products.

1947 – Arthur G. Holstein, chemist and holder of five biochemical processing patents joins Pfanstiehl, managing the fine chemical division.

1954 – Babson sells fine chemical division to Arthur Holstein and carbohydrate chemist Doctor Waldersee Hendrey, who then name their company Pfanstiehl Laboratories, Inc.

1959 – Company significantly expands capacity and capabilities by moving to its current address in Waukegan.

1962 – Upon the untimely death of Doctor Hendrey, Arthur Holstein acquires all Pfanstiehl voting shares under terms of their business agreement.

1977 – Pfanstiehl partners with Abbott Laboratories to develop a process for producing egg yolk phospholipid (egg lecithin) for use in a parenteral nutrition formulation.

1992 – Dedicated sodium lactate solutions manufacturing facility constructed.

1999 – New multi-purpose commercial scale High Potency Substance (HPS) manufacturing facility constructed.

2000 – Pfanstiehl becomes a wholly-owned subsidiary of the Ferro Corporation, a major international producer of performance materials for industry, including coatings, fine chemicals and polymer additives.

2001 – High Potency Substance (HPS) manufacturing facility and practices certified by SafeBridge Consultants, Inc.

2003 – Synthesis Isolator added to High Potency Substance (HPS) manufacturing facility to accommodate additional early phase Oncology Drug Candidate Development Programs.

2006 – Construction of new and expanded Analytical Testing Laboratory and Methods Development and Validation Laboratories New Kilo Lab and Pilot Plant facilities begin supporting Custom Synthesis and HPS Manufacturing Services (Phase I)